Combining blood-based biomarkers to predict risk for Alzheimer’s disease dementia

被引:0
作者
Suzanne E. Schindler
Randall J. Bateman
机构
[1] Washington University School of Medicine,Department of Neurology
[2] Washington University School of Medicine,Knight Alzheimer’s Disease Research Center
[3] Washington University School of Medicine,Hope Center for Neurological Disorders
来源
Nature Aging | 2021年 / 1卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Accurate blood tests for Alzheimer’s disease (AD) are critical tools that have the potential to revolutionize dementia research, clinical trials and clinical care. Models combining blood-based biomarkers that represent multiple aspects of AD brain pathology with key individual level factors may improve prediction of AD dementia.
引用
收藏
页码:26 / 28
页数:2
相关论文
共 23 条
[21]  
Klunk WE(undefined)undefined undefined undefined undefined-undefined
[22]  
Sperling RA(undefined)undefined undefined undefined undefined-undefined
[23]  
Rabinovici GD(undefined)undefined undefined undefined undefined-undefined